MGP and prostate carcinoma: Similarly, overexpression of MGP was observed in primary renal and prostatic carcinomas (Levedakou et al., 1992), while a loss of MGP expression in metastatic renal cell carcinoma and prostatic carcinoma as compared to the primary tumors was also reported (Levedakou et al., 1992).